The Impact of Methotrexate on Proliferative LN

It doesn't seem that it can obviate the need for a biopsy. It's not like a liquid biopsy, but this may help you identify those patients that are at highest risk for nephritis and then getting them to nephrology to get a biopsies. Time will tell whether or not how specific this is. You know, I think it also makes me think about the data from the STOP RA trial, which just use hydroxychloroquine in the CCP positive; they certainly don't classify for RA. And again do you treat with high intensity therapies to be able to mitigate immunosuppression time before acquisition of certain symptoms? This equation is going to